Real-time enrollment status for this recurrent diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 10:28 AM UTC
| NCT Number | NCT07676877 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Diffuse Large B-Cell Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 18 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Nathan Denlinger |
| Last Updated on CT.gov | October 9, 2026 (1 week ago) |
As of October 16, 2026: Clinical trial NCT07676877 is currently recruiting participants. This phase1 study for recurrent diffuse large b-cell lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Nathan Denlinger. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07676877 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07676877 was last updated 1 week ago (October 9, 2026). HelloStudys verifies this status automatically.